Current Law Journal Content
Washington & Lee Law School
  Current Law Journal Content
                  an index to legal periodicals
 


  Biotechnology Law Report
  Volume 29, Number 5, October 2010
  homepage                   other issues
 

  • ARTICLE
  • Collaborative Licensing in Biotechnology: A Survey of Knowledge, Experience, and Attitudes in Australia
        Dianne Nicol
        p.465-483                                                                              +cite        

  • COMMENTS ON RECENT CASES
  • EPO Enlarged Board of Appeal Decides on Dosage Regimens (G2/08) and Treatment by Surgery (G1/07)
        Franz-Josef Zimmer, Benjamin Quest
        p.485-491                                                                              +cite        
  • Bilski v. Kappos: A Preliminary Analysis
        Harold C. Wegner
        p.493-495                                                                              +cite        

  • REGULATORY AFFAIRS—PHARMACEUTICAL
  • FDA Publishes Guidance on Financial Conflicts of Interest; FDA Calls for Better Security; Concerns About Direct-to-Consumer Genetic Testing; Monoclonal Antibody for Osteoporosis Approved; New Treatment from Genzyme for Late-Onset Genetic Disease; Washington Legal Foundation Seeks Reversal of West Virginia Decision
        p.497-500                                                                              +cite    

  • REGULATORY AFFAIRS—AGRICULTURAL AND ENVIRONMENTAL
  • Alfalfa Case Sent Back for Re-Analysis
        p.501-508                                                                              +cite    

  • PATENTS
  • Georgia Inventor Finally Wins a Partial Victory; Says Suits Against Academics; Are Inhibiting Clinical Introduction of Medical Discoveries; PTO Will Reinstate Patent on Personalized Vaccine for B-Cell Malignancies; BPAI Denies Rehearing Request; Enzo Keeps DNA Technology; Update from The Medicines Company; Angiomax Patent Term Extended; PTO Modifies Review of Appeal Briefs; PTO Changes Interference Rules to Comply with Agilent
        p.509-510                                                                              +cite    

  • PATENT LITIGATION
  • Mice Do Not Infringe
        p.511                                                                                      +cite    

  • LITIGATION
  • Scientist Wins Suit Alleging Dismissal for Raising Safety Concerns
        p.513                                                                                      +cite    

  • MEDICAL AND SCIENTIFIC DEVELOPMENTS
  • Venter's Group Creates First Synthetic Cell; Both Excitement and Demands Work Be Banned
        p.515-516                                                                              +cite    

  • MISCONDUCT
  • Physician Who Claimed MMR Vaccine Causes Autism Loses License to Practice; Medicine; Allegations Not Part of Decision; Many Papers from Mayo Immunology Laboratory Being Retracted; Senior Lancet Editor Fired over Editorial; She Said Editor Changed It in Ways She Objected to
        p.517-518                                                                              +cite    

  • DOCUMENTS
  • Monsanto Co. et al. v. Geertson Seed Farms et al.
        p.519-537                                                                              +cite    
  • Monsanto Co. et al. v. Geertson Seed Farms et al. Brief for Petitioners [excerpts]
        p.539-551                                                                              +cite    
  • Monsanto Co. et al. v. Geertson Seed Farms et al. Brief for Respondents [excerpts]
        p.553-565                                                                              +cite    
  • Monsanto Co. et al. v. Geertson Seed Farms et al. Reply Brief for Petitioners [excerpts]
        p.567-572                                                                              +cite    
  • Bilski et al. v. Kappos, Under Secretary of Commerce for Intellectual Property
        p.573-599                                                                              +cite    
  • Coming Events
        p.601-605                                                                              +cite